Insider: Harris Erik EVP & Chief Commercial Officer - Ultragenyx Pharmaceutical Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 87,855 | 0 | 87,855 |
| Value | $2,476,632.45 | $0.00 | $2,476,632.45 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/03/2025 | DDS | 15,103 | Direct | COM | $42.10 | $635,836.30 | 87,855 |
| 03/01/2024 | DDS | 4,768 | Direct | COM | $53.76 | $256,327.68 | 67,163 |
| 09/05/2023 | DDS | 6,000 | Direct | COM | $37.96 | $227,760.00 | 51,281 |
| 06/19/2023 | DDS | 305 | Direct | COM | $48.20 | $14,701.00 | 57,281 |
| 03/01/2023 | DDS | 3,664 | Direct | COM | $45.25 | $165,796.00 | 57,344 |
| 03/01/2022 | DDS | 2,713 | Direct | COM | $66.62 | $180,740.06 | 22,317 |
| 10/14/2021 | DDS | 303 | Direct | COM | $81.14 | $24,585.42 | 25,030 |
| 07/06/2021 | DDS | 375 | Direct | COM | $91.53 | $34,323.75 | 25,333 |
| 06/21/2021 | DDS | 572 | Direct | COM | $94.96 | $54,317.12 | 25,708 |
| 06/19/2021 | DDS | 437 | Direct | COM | $94.63 | $41,353.31 | 26,280 |
| 05/07/2021 | DDS | 393 | Direct | COM | $113.67 | $44,672.31 | 26,717 |
| 05/06/2021 | DDS | 307 | Direct | COM | $113.68 | $34,899.76 | 27,110 |
| 04/20/2021 | DDS | 396 | Direct | COM | $104.28 | $41,294.88 | 27,417 |
| 03/02/2021 | DDS | 707 | Direct | COM | $138.16 | $97,679.12 | 27,813 |
| 03/01/2021 | DDS | 2,470 | Direct | COM | $138.17 | $341,279.90 | 28,520 |
| 10/14/2020 | DDS | 220 | Direct | COM | $88.00 | $19,360.00 | 23,370 |
| 06/03/2020 | DDS | 2,516 | Direct | COM | $74.69 | $187,920.04 | 20,854 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research